BeiGene stock has large players volume exploding higher. The company reported eye-popping earnings and revenue beats this week.
Sorrento Therapeutics Inc has bounced off its 61.8 percent Fibonacci retracement level. Sorrento Therapeutics had a decline in short interest in the month of September. As of September 29th, there
April 16, 2017: Sell Cancer Genetics for an incredible 133% win in 85 days and congratulations if you made money on the trade. December 9, 2016: H.C. Wainwright/ Rodman & Renshaw